الفهرس 
Clinical PresentationOnly 14 pages are availabe for public view
 |  | from | 190 |  |  |
| | | from | 190 | | |
Abstract
Basal cell carcinoma (BCC) is a malignant tumor of the skin thought to arise from a hair follicle. It resembles the undifferentiated cells of basal layer of the epidermis.
Etiology and risk factors of basal cell carcinoma include:
Exposure to ultraviolet irradiation, ionizing radiation, hereditary factor, arsenic exposure, immunosuppression, xeroderma pigmentosum, nevoid BCC syndrome, bazex syndrome, history of previous nonmelanoma skin cancer.
It has different clinical presentations including:
Nodular BCC, pigmented BCC, cystic BCC, superficial BCC, micronodular BCC, morpheaform BCC, infiltrating BCC and naevoid basal cell carcinoma syndrome.
Treatment of basal cell carcinoma is by either medical treatment in the form of: 5-fluorouracil and interferon alfa-2b or surgical treatment in the form of curettage, surgical excision, mohs micrographic surgery, radiotherapy, laser therapy and cryosurgery.